• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prognostic knowledge: interest and methods.

作者信息

Chastang C, Auquier A, Gremy F

出版信息

Bull Cancer. 1980;67(4):430-6.

PMID:7013863
Abstract

The value of prognostic information and some of the statistical aspects of prognostic studies are discussed. In the first part, seven areas of medical activity where knowledge of prognostic factors is used are identified: prediction of disease evolution, treatment decisions, design and analysis of clinical trials, comparison of non-randomized series of patients, assessment of additional clinical examinations and laboratory tests, understanding of the physio-pathology of disease, screening. In the second part, the nature of the data collected in prognostic studies is discussed, and a few statistical methods useful for the identification of prognostic factors are outlined. The paper concludes with an example of a prognostic study in Chronic Lymphocytic Leukemia.

摘要

相似文献

1
Prognostic knowledge: interest and methods.
Bull Cancer. 1980;67(4):430-6.
2
[Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].[预后知识在随机治疗试验的规划与分析中的应用]
Bull Cancer. 1987;74(2):177-84.
3
Statistical comparison of random allocation methods in cancer clinical trials.癌症临床试验中随机分配方法的统计学比较。
Control Clin Trials. 2004 Dec;25(6):572-84. doi: 10.1016/j.cct.2004.08.004.
4
Importance of prognostic factors in cancer clinical trials.
Cancer Treat Rep. 1984 Jan;68(1):185-92.
5
Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.慢性淋巴细胞白血病:新的预后因素及其与风险适应性治疗策略的相关性。
Haematologica. 2005 Mar;90(3):391-9.
6
Designs for experiments--parallel comparisons of treatment.
N Engl J Med. 1983 Nov 24;309(21):1291-9. doi: 10.1056/NEJM198311243092105.
7
Prognostic factors in clinical cancer trials.临床癌症试验中的预后因素。
Clin Cancer Res. 1997 Dec;3(12 Pt 2):2591-3.
8
[Chronic lymphocytic leukemia. Is staging or prognostic grouping of chronic lymphocytic leukemia relevant to the choice of treatment?].[慢性淋巴细胞白血病。慢性淋巴细胞白血病的分期或预后分组与治疗选择相关吗?]
Tidsskr Nor Laegeforen. 1985 Oct 20;105(29):2066-9.
9
Randomized clinical trials. Perspectives on some recent ideas.随机临床试验。对一些近期观点的看法。
N Engl J Med. 1976 Jul 8;295(2):74-80. doi: 10.1056/NEJM197607082950204.
10
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.选择高风险基因特征可预测慢性淋巴细胞白血病患者接受氟达拉滨和利妥昔单抗化学免疫治疗后疾病进展更早:风险适应性治疗的依据
J Clin Oncol. 2006 Jan 20;24(3):437-43. doi: 10.1200/JCO.2005.03.1021. Epub 2005 Dec 12.